Th e aim of this article was to investigate the correlation between expression of O  -methylguanine-DNA methyltransferase (MGMT) in osteosarcoma and the curative eff ect of alkylating agent (Cis-diaminodichloroplatinum, CDDP).  male patients and  female patients with a median age of  years ( to  years) were eligible for this study. According to histopathological types, there were  cases of telangiectatic osteogenic sarcoma,  cases of osteoblastic,  cases of chondroblastic and  cases of fi broblastic sarcoma. Immunohistochemical method was used to detect the expression of MGMT protein. Th e correlations between MGMT expression and the curative eff ect of CDDP on osteosarcoma have been investigated. It was shown by immunohistochemical staining that among  osteosarcoma biopsy specimens,  () cases were positive,  () cases were weak positive,  (), cases were moderate positive, and  () cases were strong positive. Th ere were no signifi cant diff erences in MGMT expression among diff erent pathological types of tumors (p>.). After CDDP chemotherapy, among pathologic specimens in which MGMT expression was positive, necrosis rates were as follows: grade I,  cases (); grade II,  cases (); grade III,  cases (); grade IV,  cases (). Osteosarcoma necrosis rate was low when the expression of MGMT protein was positive, whereas necrosis rate was high when there was a low level of MGMT expression (p<.). Th ere was a signifi cant negative correlation between the level of MGMT expression in osteosarcoma tissue and osteosarcoma necrosis rate after cisplatin chemotherapy. 
INTRODUCTION
Chemotherapy plays a key role in the comprehensive treatment of osteosarcoma. It has significantly increased the -year survival rate of osteosarcoma patients as well as the success rate of limb salvage surgeries. Nowadays, Cis-diaminodichloroplatinum (CDDP) has been widely used in chemotherapy in treatment for bone and soft tissue malignancy, but the problem of drug resistance has not yet been completely solved via this protocol. Results of intensive study on cell and molecular biology indicate that, to a large extent, the drug resistance of tumor cell are caused by two aspects. On the one hand, gene MDRL encoding protein P-gp can actively transport the chemotherapeutic agents outside the cell, thus reducing the intracellular eff ective concentration, which makes the tumor cell escape the cytotoxicity of drugs. On the other hand, the strong repair function of tumor cell can signifi cantly weaken the therapeutic eff ect of drugs. How to predict and conquer drug resistance of tumor cell is of great importance in tumor therapy. Many studies have demonstrated that MGMT can rapidly repair alkylating damage of DNA, which is the main reason of tumor cell to develop drug tolerance [-] . Researchers around the world have conducted individualized clinical experiments based on inhibiting MGMT activity as well as the rational use of alkylating agent [-] . MGMT can repair methylation and alkylation damage of guanine base in DNA, thus counteracting the killing eff ect of alkylating agent on tumor cells, which is a main determinant of resistance of tumor cells to chemotherapeutic alkylating agents. It was found that there was a negative correlation between high level of MGMT expression in tumor tissue and curative eff ect of alkylating agents [] . Th erefore, in this comparative study, we have investigated the relationship between MGMT expression and the curative eff ect of CDDP on osteosarcoma.
MATERIALS AND METHODS

Patients
Between January  and April ,  patients with osteosarcoma (aged between  to  years old, no other pathological types of tumors were found in these patients) were eligible for this study. After admission, pre-treatment pathological tissue samples were collected, MGMT pro- 

Detection of MGMT protein expression in osteosarcoma patients by immunohistochemical method
Immunohistochemical staining was conducted according to standard procedure strictly. Samples were observed under light microscope. After dewaxing and dehydration, tissues were formalin fixed and paraffin embedded, then placed into hydrogen peroxide solution (.) for  minutes to inactivate endogenous enzyme. After washed off by PBS and blocked, samples were treated with fi rst antibody at °C overnight. Th ey were washed off using PBS the next day, and then were incubated with second antibody at °C for °C for  minutes. Finally, samples were washed conventionally, and then were colored using DAB chromogenic reagent. Cell nuclear and cytoplasm were stained by MGMT antibodies. Under microscope, karyoplasms that were brown colored and distinct from the background were considered as positive, conversely, they were considered as negative.
Determinant criterion of MGMT expression staining results
Th e positive immunohistochemical reaction was observed as light or dark reed colouring of the tumor nuclei and cytoplasm. Samples that were strongly stained, in which the proportion of positive cells was above  were considered as strong positive (+++); cases where the proportion of stained cells was between ~ were considered as moderate positive (++); samples that were weakly stained, in which the proportion of stained cells was blow  were considered as weak positive (+). All detection results were evaluated via double-blind trial by researchers.
Curative eff ect evaluation according to detection results of post chemotherapeutic tumor tissue necrosis
Grade I: Light response. A few tumor necroses appeared. Th e necrosis rate was no greater than  . Grade II: Moderate response. Tumors were partially necrotic. Necrosis rate was between  and . Th ere was sporadic loose fi brous tissue hyperplasia scattered in the sample. Regional survived tumor cells still existed. Grade III: Most of the tumor cells were necrotic. Necrosis rate was between  and . Th ere were only sporadic survived tumor lesions scattered in the sample. Fibrous tissue hyperplasia can be found. Grade IV: Tumor necrosis rate was . Fibrous tissue hyperplasia can be found.
Statistical analysis
Statistical analyses were done by SPSS . software. Experimental data and the statistical significance were analyzed by χ  test and variance analysis respectively. p<. represented that the differences were of statistical significance. Table ) . Results showed that osteosarcoma tissue with negative expression of MGMT was sensitive to CDDP. There was a negative correlation between the expression of MGMT and osteosarcoma necrosis condition after chemotherapy. Th e necrosis of tumor lesion was mild after chemotherapy when there was a strong positive expression of MGMT.
DISCUSSION
Recently, the increases of -year survival rate and the success rate of limb salvage surgery benefi t from the important role chemotherapy played in the comprehensive treatment of osteosarcoma. These days, neo-adjuvant chemotherapy has been widely used around the world, but this treatment protocol still cannot solve completely the problem of drug resistance after chemotherapy. The MGMT expressions of the pathological samples of the osteosarcoma and the tumor necrosis rates after chemotherapy have been comprehensively analyzed. It can be concluded from our experimental results that MGMT protein expression has certain significances in the prediction of CDDP chemotherapeutic effect of the osteosarcoma patient. Study show that the antineoplastic alkylating agents could cause DNA base alkylation. The formation of O  -methylguanine is considered to have the most threatening eff ect on cellular activity. O  -methylguanine can cause G: CoA: T mutation, which results in cell mutation and death. MGMT is a special DNA repair enzyme universally existed in biological organisms from bacteria to mammalian. It functions as transferase and methyl acceptor simultaneously. MGMT can repair guanine damage in DNA by transferring alkylating groups from O  position to its own cysteine residues before DNA cross-linking, and meanwhile loses its activity irreversibly. Other proteins have not been found to participate in this process so far. Th erefore, MGMT is the molecular basis for cells to develop drug resistance to alkylating agents [-] . CDDP functions similarly to the double functional groups of alkylating agent by inhibiting DNA synthesis. Preuss et al. [] have found that tumor cell in which MGMT has high level of activity is resistant to CDDP, whereas tumor cell is sensitive to CDDP when MGMT activity is low. Bruheim et al. [] studied the relationship between MGMT activity and the curative eff ect of two chemotherapeutic drugs (cytoxan (CTX) and CDDP) on tumor xenografts. Th ey inoculated  tumor cell lines into right armpits of nude mice, and then injected CTX and CDDP respectively. Results showed that the higher the MGMT activity was, the less sensitive the tumor cell to CTX. No such correlation was found with CDDP. Eichhorn et al. [] demonstrated that drug resistance of tumor cell to chemotherapeutic agent CTX was positively correlated with MGMT expression. There are no significant differences in MGMT expression among diff erent pathological types (p>.) according to our detection results. We have analyzed MGMT expressions in osteosarcoma biopsy specimens and necrosis rates that indirectly refl ect curative eff ects of chemotherapy. We have found that MGMT expression is negatively correlated with osteosarcoma necrosis rate after chemotherapy (p<.). Necrosis rate of tumor samples with negative or weak positive MGMT expression is higher than that with strong positive expression. Although the mechanism of tumor cells having the potential to develop resistance to chemotherapeutic alkylating agents has not been completely understood, exciting advances have been achieved in curative effect of treatment in some tumor cell lines by inhibiting MGMT activity combined with alkylating administration. Detection of the level of MGMT activity helps to make the alkylating chemotherapy for the treatment of osteosarcoma and other carcinomatous diseases more predictably.
CONCLUSION
In conclusion, there were no significant differences in MGMT expression among different pathological types of tumors (p>.). After CDDP chemotherapy, among pathologic specimens in which MGMT expression was positive, necrosis rates were as follows: grade I,  cases (); grade II,  cases (); grade III,  cases (); grade IV,  cases (). Osteosarcoma necrosis rate was low when the expression of MGMT protein was positive, whereas necrosis rate was high when there was a low level of MGMT expression (p<.). Th ere was a signifi cant negative correlation between the level of MGMT expression in osteosarcoma tissue and osteosarcoma necrosis rate after cisplatin chemotherapy.
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